AI Health & Biotechnology
AI Tool PhenMap Predicts Bowel Cancer Treatment Success
Researchers from the ICR and RCSI developed an AI system to identify which patients benefit from targeted drug therapy.
A medical monitor in a laboratory showing genetic data maps and a bowel anatomy model used for cancer treatment prediction.
Photo: Kronos News
Researchers at the Institute of Cancer Research and RCSI have developed a new AI tool called PhenMap [1][2]. This system predicts how patients with advanced bowel cancer will respond to the targeted drug bevacizumab [1][3]. By analyzing complex genetic and clinical data, the tool identifies individuals for whom the treatment might fail [1][2]. This breakthrough allows doctors to tailor treatments more effectively for each patient [2]. By identifying ineffective therapies early, the system spares patients from unnecessary side effects [3]. The development represents a significant step forward in using artificial intelligence to improve precision medicine [1][2].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
theguardian.com
https://www.theguardian.com/society/2026/apr/13/ai-bowel-cancer-patients-nhs-drug
- 2.↗
icr.ac.uk
https://www.icr.ac.uk/about-us/icr-news/detail/scientists-develop-new-way-to-determine-which-patients-will-respond-best-to-bowel-cancer-treatment
- 3.↗
pharmaphorum.com
https://pharmaphorum.com/news/ai-could-spare-bowel-cancer-patients-unneeded-treatment
Related stories
View all
Topics
About the author
Kronos News Desk covers ai health & biotechnology and editorial analysis for Kronos News.